{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:08:56Z","timestamp":1780582136574,"version":"3.54.1"},"reference-count":63,"publisher":"Scientific Scholar","content-domain":{"domain":["ijdvl.com"],"crossmark-restriction":true},"short-container-title":["IJDVL"],"abstract":"<jats:p>Ras\/mitogen-activated protein kinase pathway dysregulation results in a group of disorders, collectively termed as RASopathies. Neurofibromatosis type 1, Noonan syndrome, Noonan syndrome with multiple lentigines, Noonan syndrome\/loose anagen hair, Legius syndrome, Costello syndrome, cardio-facio-cutaneous syndrome and capillary malformation-arteriovenous malformation are the well-recognized RASopathies. These are characterized by multi-organ tumours and hamartomas. Some other features in common are facial dysmorphism, skeletal abnormalities, congenital heart disease, neurocognitive abnormalities and risk of various solid-organ and haematological malignancies. Some of the RASopathies are heterogeneous, caused by several gene mutations resulting in variations in phenotypes and severity ranging from mild to fatal. Significant phenotypic overlaps among different disorders, often makes it difficult to pinpoint a clinical diagnosis. Specific cutaneous manifestations are present in some of the RASopathies and are often the earliest clinical signs\/symptoms. Hence, dermatologists contribute significantly as primary care physicians by identifying disorder-specific cutaneous lesions. However, diagnostic work-up and management of these disorders are often multidisciplinary. Confirmation of diagnosis is possible only by genetic mapping in each case. Genetic counseling of the patients and the affected families is an important component of the management. The aim of this review is description of cutaneous manifestations of RASopathies in the background of multi-system involvement to enable dermatologists a comprehensive and logical approach to work up and diagnose such patients in the absence of facility for specific molecular testing.<\/jats:p>","DOI":"10.25259\/ijdvl_799_20","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T06:17:54Z","timestamp":1640672274000},"page":"452-463","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["RASopathies: Dermatologists\u2019 viewpoints"],"prefix":"10.25259","volume":"88","author":[{"given":"Aparna","family":"Palit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun C.","family":"Inamadar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprosy, Shri B. M. Patil Medical College, Hospital and Research Center, BLDE University, Vijayapur, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2021,12,27]]},"reference":[{"key":"10.25259\/IJDVL_799_20\/ref-1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajmg.a.36793","article-title":"Recent developments in neurofibromatosis and RASopathies: Management, diagnosis and current and future therapeutic avenues","volume":"167A","author":"Rauen","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.25259\/IJDVL_799_20\/ref-2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1365-2133.2011.10744.x","article-title":"Dermatological phenotype in Costello syndrome: Consequences of ras dysregulation in development","volume":"166","author":"Siegel","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.25259\/IJDVL_799_20\/ref-3","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1002\/ajmg.a.37723","article-title":"The fourth international symposium on genetic disorders of the RAS\/MAPK pathway","volume":"178","author":"Stevenson","year":"2016","journal-title":"Am J Med Genet A"},{"key":"10.25259\/IJDVL_799_20\/ref-4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","article-title":"The RASopathies","volume":"14","author":"Rauen","year":"2013","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.25259\/IJDVL_799_20\/ref-5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/ajmg.b.32632","article-title":"RASopathies are associated with a distinct personality profile","volume":"174","author":"Bizaoui","year":"2018","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.25259\/IJDVL_799_20\/ref-6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40142-016-0100-7","article-title":"Expansion of the RASopathies","volume":"4","author":"Tidyman","year":"2016","journal-title":"Curr Genet Med Rep"},{"key":"10.25259\/IJDVL_799_20\/ref-7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/jmedgenet-2013-101951","article-title":"Autism traits in RASopthies","volume":"51","author":"Adviento","year":"2014","journal-title":"J Med Genet"},{"key":"10.25259\/IJDVL_799_20\/ref-8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s11689-018-9239-8","article-title":"Social skills in children with RASopathoies: A comparison of Noonan syndrome and neurofibromatosis Type-1","volume":"10","author":"Pierpont","year":"2018","journal-title":"J Neurodev Dis"},{"key":"10.25259\/IJDVL_799_20\/ref-9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000331266","article-title":"Rasopathies: Clinical diagnosis in the first year of life","volume":"1","author":"Digilio","year":"2010","journal-title":"Mol Syndromol"},{"key":"10.25259\/IJDVL_799_20\/ref-10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","article-title":"Noonan Syndrome","volume":"381","author":"Roberts","year":"2013","journal-title":"Lancet"},{"key":"10.25259\/IJDVL_799_20\/ref-11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4161\/cc.23108","article-title":"Mosaic RASopathies","volume":"12","author":"Hafner","year":"2013","journal-title":"Cell Cycle"},{"key":"10.25259\/IJDVL_799_20\/ref-12","first-page":"4682","article-title":"Ras oncogenes in human cancer: A review","volume":"49","author":"Bos","year":"1989","journal-title":"Cancer Res"},{"key":"10.25259\/IJDVL_799_20\/ref-13","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1042\/BST0351329","article-title":"Mouse models for BRAF-induced cancers","volume":"35","author":"Pritchard","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"10.25259\/IJDVL_799_20\/ref-14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/ajmg.c.30294","article-title":"Costello and Cardio-Facio-Cutaneous syndromes: Moving toward clinical trials in RASopathies","volume":"157C","author":"Rauen","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.25259\/IJDVL_799_20\/ref-15","doi-asserted-by":"publisher","first-page":"R123","DOI":"10.1093\/hmg\/ddw191","article-title":"Pathogenesis of the RASopathies","volume":"25","author":"Tidyman","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.25259\/IJDVL_799_20\/ref-16","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1086\/379793","article-title":"Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RAS1 mutation","volume":"73","author":"Eerola","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.25259\/IJDVL_799_20\/ref-17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/JBM.S164474","article-title":"Evaluation of bleeding disorders in patients with Noonan syndrome: A systematic review","volume":"9","author":"Nugent","year":"2018","journal-title":"J Blood Med"},{"key":"10.25259\/IJDVL_799_20\/ref-18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S1470-2045(09)70033-6","article-title":"Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis Type 1","volume":"10","author":"Brems","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.25259\/IJDVL_799_20\/ref-19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.14348\/molcells.2019.0037","article-title":"Neurodevelopmental aspects of RASopathies","volume":"42","author":"Kim","year":"2019","journal-title":"Mol Cells"},{"key":"10.25259\/IJDVL_799_20\/ref-20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5114\/aoms.2017.64720","article-title":"Noonan syndrome-a new survey","volume":"13","author":"Tafazoli","year":"2017","journal-title":"Arch Med Sci"},{"key":"10.25259\/IJDVL_799_20\/ref-21","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1542\/peds.2009-3207","article-title":"Noonan syndrome: Clinical features, diagnosis and management guidelines","volume":"126","author":"Romano","year":"2010","journal-title":"Pediatrics"},{"key":"10.25259\/IJDVL_799_20\/ref-22","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1111\/bjd.17077","article-title":"Dermatological manifestations in Noonan syndrome: A multicentric study of 129 patients positive for mutation","volume":"180","author":"Bessis","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.25259\/IJDVL_799_20\/ref-23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1086\/341528","article-title":"Grouping of Multiple-Lentigines\/LEOPARD and Noonan syndromes on the PTPN11 gene","volume":"71","author":"Digilio","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.25259\/IJDVL_799_20\/ref-24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.gde.2005.03.004","article-title":"RASA1: Variable phenotype with capillary and arteriovenous malformations","volume":"15","author":"Boon","year":"2005","journal-title":"Curr Opin Genet Dev"},{"key":"10.25259\/IJDVL_799_20\/ref-25","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/jmg.2009.075374","article-title":"Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcoma","volume":"47","author":"Bourdeaur","year":"2010","journal-title":"J Med Genet"},{"key":"10.25259\/IJDVL_799_20\/ref-26","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/ng.2316","article-title":"Postzygotic HRAS and KRAS mutations cause nevus sebaceous and schimmelpenning syndrome","volume":"44","author":"Groesser","year":"2012","journal-title":"Nat Genet"},{"key":"10.25259\/IJDVL_799_20\/ref-27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s00439-003-1047-9","article-title":"Genetic and clinical mosaicism in a patient with neurofibromatosis Type 1","volume":"114","author":"Vandenbroucke","year":"2004","journal-title":"Hum Genet"},{"key":"10.25259\/IJDVL_799_20\/ref-28","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1056\/NEJMc1109381","article-title":"HRAS mutation mosaicism causing urothelial cancer and epidermal nevus","volume":"365","author":"Hafner","year":"2011","journal-title":"N Engl J Med"},{"key":"10.25259\/IJDVL_799_20\/ref-29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ajmg.a.32639","article-title":"Male-to-male transmission of Costello syndrome: Inherited G12S HRAS germline mutation inherited from a father with somatic mosaicism","volume":"149A","author":"Sol-Church","year":"2009","journal-title":"Am J Med Genet A"},{"key":"10.25259\/IJDVL_799_20\/ref-30","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/ajmg.a.31456","article-title":"Somatic mosaicism for an HRAS mutation causes Costello syndrome","volume":"140A","author":"Gripp","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.25259\/IJDVL_799_20\/ref-31","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0190-9622(87)80249-9","article-title":"Lethal genes surviving by mosaicism. A possible explanation for sporadic birth defects involving the skin","volume":"16","author":"Happle","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.25259\/IJDVL_799_20\/ref-32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13023-017-0756-4","article-title":"Congenital anomalies in neurofibromatosis 1: A retrospective register-based total population study","volume":"13","author":"Lepp\u00e4virta","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.25259\/IJDVL_799_20\/ref-33","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJM199706123362404","article-title":"Homozygous inactivation of the NF1 genes in bone marrow cells from children with neurofibromatosis Type 1 and malignant myeloid disorders","volume":"336","author":"Side","year":"1997","journal-title":"N Engl J Med"},{"key":"10.25259\/IJDVL_799_20\/ref-34","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis Type 1 revisited","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"key":"10.25259\/IJDVL_799_20\/ref-35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13023-018-0881-8","article-title":"Craniofacial and oral alterations in patients with neurofibromatosis 1","volume":"13","author":"Visnapuu","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.25259\/IJDVL_799_20\/ref-36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13023-020-1310-3","article-title":"Neurofibromatosis 1. French national guidelines based on an extensive literature review since 1966","volume":"15","author":"Bergqvist","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.25259\/IJDVL_799_20\/ref-37","doi-asserted-by":"publisher","first-page":"e1180","DOI":"10.1002\/mgg3.1180","article-title":"Expanding the Noonan spectrum\/RASopathy NGS panel: Benefits of adding NF1 and SPRED 1","volume":"8","author":"Witkowski","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"10.25259\/IJDVL_799_20\/ref-38","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3390\/genes10080580","article-title":"Clinical and genetic findings in children with neurofibromatosis Type 1, Legius syndrome and other related neurocutaneous disorders","volume":"10","author":"Giugliano","year":"2019","journal-title":"Genes"},{"key":"10.25259\/IJDVL_799_20\/ref-39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/14728222.2018.1465931","article-title":"Emerging therapeutic targets for neurofibromatosis Type 1 (NF1)","volume":"22","author":"Walker","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"10.25259\/IJDVL_799_20\/ref-40","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1086\/510781","article-title":"An absence of cutaneous neurofibromas associated with a 3-bp in frame deletion in Exon 17 of the NF1 gene (c2970-2972 del ATT): Evidence of a clinically significant NF1 genotype-phenotype correlation","volume":"80","author":"Upadhyaya","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.25259\/IJDVL_799_20\/ref-41","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41436-018-0269-0","article-title":"Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): An update of genotype-phenotype correlation","volume":"21","author":"Koczkowska","year":"2019","journal-title":"Genet Med"},{"key":"10.25259\/IJDVL_799_20\/ref-42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00439-017-1766-y","article-title":"Emerging genotypephenotype relationships in patients with large NF1 deletions","volume":"136","author":"Kehrer-Sawatzki","year":"2017","journal-title":"Hum Genet"},{"key":"10.25259\/IJDVL_799_20\/ref-43","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","article-title":"Conference statement. National institutes of health consensus development conference","volume":"45","author":"Neurofibromatosis","year":"1988","journal-title":"Arch Neurol"},{"key":"10.25259\/IJDVL_799_20\/ref-44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/ocr.12144","article-title":"A review of craniofacial and dental findings of the RASopathies","volume":"20","author":"Cao","year":"2017","journal-title":"Orthod Craniofac Res"},{"key":"10.25259\/IJDVL_799_20\/ref-45","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00431-018-3183-1","article-title":"Ocular findings in Noonan syndrome: A retrospective cohort study of 105 patients","volume":"177","author":"van Trier","year":"2018","journal-title":"Eur J Pediatr"},{"key":"10.25259\/IJDVL_799_20\/ref-46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1172-3-13","article-title":"Leopard syndrome","volume":"3","author":"Sarkozy","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.25259\/IJDVL_799_20\/ref-47","doi-asserted-by":"publisher","first-page":"437","DOI":"10.5114\/pdia.2017.70330","article-title":"Craniofacial and cutaneous findings in Noonan, Costello and LEOPARD syndromes","volume":"35","author":"Pokrowiecki","year":"2018","journal-title":"Postepy Dermatol Alergol"},{"key":"10.25259\/IJDVL_799_20\/ref-48","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1525-1470.2008.00734.x","article-title":"LEOPARD syndrome: What are Caf\u00e9 Noir spots?","volume":"25","author":"Rodr\u00edguez-Bujald\u00f3n","year":"2008","journal-title":"Pediatr Dermatol"},{"key":"10.25259\/IJDVL_799_20\/ref-49","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/bjd.17731","article-title":"The value of dermatological phenotyping in the clinical diagnosis of RASopathies","volume":"180","author":"Carcavilla","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.25259\/IJDVL_799_20\/ref-50","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1101\/gad.190876.112","article-title":"A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1","volume":"26","author":"Stowe","year":"2012","journal-title":"Genes Dev"},{"key":"10.25259\/IJDVL_799_20\/ref-51","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1534\/g3.111.000687","article-title":"The SPRED1 variants repository for Legius syndrome","volume":"1","author":"Sumner","year":"2011","journal-title":"G3 (Bethesda)"},{"key":"10.25259\/IJDVL_799_20\/ref-52","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13052-015-0115-9","article-title":"Legius syndrome: Case report and review of literature","volume":"41","author":"Benelli","year":"2015","journal-title":"Ital J Pediatr"},{"key":"10.25259\/IJDVL_799_20\/ref-53","doi-asserted-by":"publisher","first-page":"iii78","DOI":"10.1093\/neuonc\/now075.55","article-title":"Case report of an optic pathway glioma in a patient with Legius syndrome","volume":"18","author":"Skrypek","year":"2016","journal-title":"Neurooncology"},{"key":"10.25259\/IJDVL_799_20\/ref-54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/ajmg.c.30297","article-title":"Observations on intelligence and behaviour in 15 patients with Legius syndrome","volume":"157","author":"Denayer","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.25259\/IJDVL_799_20\/ref-55","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1001\/jama.2009.1663","article-title":"Clinical and mutational spectrum of neurofibromatosis Type 1-like syndrome","volume":"302","author":"Messiaen","year":"2009","journal-title":"JAMA"},{"key":"10.25259\/IJDVL_799_20\/ref-56","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/ng1749","article-title":"Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome","volume":"38","author":"Niihori","year":"2006","journal-title":"Nat Genet"},{"key":"10.25259\/IJDVL_799_20\/ref-57","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/bjd.17077","article-title":"Dermatological manifestations in cardio-facio-cutaneous syndrome: A prospective multicentric study of 45 mutation-positive patients","volume":"180","author":"Bessis","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.25259\/IJDVL_799_20\/ref-58","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/s41431-018-0196-1","article-title":"Expanding the clinical and molecular findings in RASA1 capillary malformation-arteriovenous malformation","volume":"26","author":"Wooderchak-Donahue","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"10.25259\/IJDVL_799_20\/ref-59","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/pde.12112","article-title":"Capillary malformation-arteriovenous malformation syndrome: Review of the literature, proposed diagnostic criteria, and recommendations for management","volume":"30","author":"Ome","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"10.25259\/IJDVL_799_20\/ref-60","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41065-018-0062-8","article-title":"A novel RASA1 mutation causing capillary malformation-arteriovenous malformation (CM-AVM): The first genetic clinical report in East Asia","volume":"155","author":"Cai","year":"2018","journal-title":"Hereditas"},{"key":"10.25259\/IJDVL_799_20\/ref-61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2045-824X-4-19","article-title":"CM-AVM Syndrome in a neonate: Case report and treatment with a novel flow reduction strategy","volume":"4","author":"Behr","year":"2012","journal-title":"Vasc Cell"},{"key":"10.25259\/IJDVL_799_20\/ref-62","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/ajmg.1320530213","article-title":"Clinical and molecular studies in a large Dutch family with Noonan syndrome","volume":"53","author":"van der Burgt","year":"1994","journal-title":"Am J Med Genet"},{"key":"10.25259\/IJDVL_799_20\/ref-63","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0002-9343(76)90764-6","article-title":"Multiple lentigines syndrome. Case report and review of literature","volume":"60","author":"Voron","year":"1976","journal-title":"Am J Med"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijdvl.com\/rasopathies-dermatologists-viewpoints\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijdvl.com\/rasopathies-dermatologists-viewpoints\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T11:52:56Z","timestamp":1679313176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijdvl.com\/rasopathies-dermatologists-viewpoints\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,27]]},"references-count":63,"alternative-id":["10.25259\/IJDVL_799_20"],"URL":"https:\/\/doi.org\/10.25259\/ijdvl_799_20","relation":{},"ISSN":["0973-3922","0378-6323"],"issn-type":[{"value":"0973-3922","type":"electronic"},{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,27]]},"article-number":"452"}}